Literature DB >> 23297725

Hospital readmission after a pancreaticoduodenectomy: an emerging quality metric?

Zachary J Kastenberg1, John M Morton, Brendan C Visser, Jeffrey A Norton, George A Poultsides.   

Abstract

BACKGROUND: Hospital readmission has attracted attention from policymakers as a measure of quality and a target for cost reduction. The aim of the study was to evaluate the frequency and patterns of rehospitalization after a pancreaticoduodenectomy (PD).
METHODS: The records of all patients undergoing a PD at an academic medical centre for malignant or benign diagnoses between January 2006 and September 2011 were retrospectively reviewed. The incidence, aetiology and predictors of subsequent readmission(s) were analysed.
RESULTS: Of 257 consecutive patients who underwent a PD, 50 (19.7%) were readmitted within 30 days from discharge. Both the presence of any post-operative complication (P = 0.049) and discharge to a nursing/rehabilitation facility or to home with health care services (P = 0.018) were associated with readmission. The most common reasons for readmission were diet intolerance (36.0%), pancreatic fistula/abscess (26.0%) and superficial wound infection (8.0%). Nine (18.0%) readmissions had lengths of stay of 2 days or less and in four of those (8.0%) diagnostic evaluation was eventually negative.
CONCLUSION: Approximately one-fifth of patients require hospital readmission within 30 days of discharge after a PD. A small fraction of these readmissions are short (2 days or less) and may be preventable or manageable in the outpatient setting.
© 2012 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2012        PMID: 23297725      PMCID: PMC3719921          DOI: 10.1111/j.1477-2574.2012.00563.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  14 in total

1.  CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections.

Authors:  T C Horan; R P Gaynes; W J Martone; W R Jarvis; T G Emori
Journal:  Infect Control Hosp Epidemiol       Date:  1992-10       Impact factor: 3.254

2.  The evolving importance of readmission data to the practicing surgeon.

Authors:  Russell E Brown; Motaz Qadan; Robert C G Martin; Hiram C Polk
Journal:  J Am Coll Surg       Date:  2010-08-21       Impact factor: 6.113

3.  Hospital readmission after pancreaticoduodenectomy.

Authors:  Dawn M Emick; Taylor S Riall; John L Cameron; Jordan M Winter; Keith D Lillemoe; Joann Coleman; Patricia K Sauter; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

Review 4.  Postoperative pancreatic fistula: an international study group (ISGPF) definition.

Authors:  Claudio Bassi; Christos Dervenis; Giovanni Butturini; Abe Fingerhut; Charles Yeo; Jakob Izbicki; John Neoptolemos; Michael Sarr; William Traverso; Marcus Buchler
Journal:  Surgery       Date:  2005-07       Impact factor: 3.982

5.  Readmission rates after abdominal surgery: the role of surgeon, primary caregiver, home health, and subacute rehab.

Authors:  Robert C G Martin; Russell Brown; Lisa Puffer; Stacey Block; Glenda Callender; Amy Quillo; Charles R Scoggins; Kelly M McMasters
Journal:  Ann Surg       Date:  2011-10       Impact factor: 12.969

6.  Effect of surgeon volume on outcome following pancreaticoduodenectomy in a high-volume hospital.

Authors:  Nicolò Pecorelli; Gianpaolo Balzano; Giovanni Capretti; Alessandro Zerbi; Valerio Di Carlo; Marco Braga
Journal:  J Gastrointest Surg       Date:  2011-11-15       Impact factor: 3.452

7.  Factors associated with recidivism following pancreaticoduodenectomy.

Authors:  Sanjeet S Grewal; Rebecca J McClaine; Nathan Schmulewitz; Mohammed A Alzahrani; Dennis J Hanseman; Jeffery J Sussman; Milton Smith; Kyuran A Choe; Olugbenga Olowokure; Michelle Mierzwa; Syed A Ahmad
Journal:  HPB (Oxford)       Date:  2011-10-26       Impact factor: 3.647

8.  Readmission after major pancreatic resection: a necessary evil?

Authors:  Tara S Kent; Teviah E Sachs; Mark P Callery; Charles M Vollmer
Journal:  J Am Coll Surg       Date:  2011-08-16       Impact factor: 6.113

9.  Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma--part 3: update on 5-year survival.

Authors:  Taylor S Riall; John L Cameron; Keith D Lillemoe; Kurtis A Campbell; Patricia K Sauter; JoAnn Coleman; Ross A Abrams; Daniel Laheru; Ralph H Hruban; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2005-12       Impact factor: 3.267

10.  Readmission after pancreatectomy for pancreatic cancer in Medicare patients.

Authors:  Deepthi M Reddy; Courtney M Townsend; Yong-Fang Kuo; Jean L Freeman; James S Goodwin; Taylor S Riall
Journal:  J Gastrointest Surg       Date:  2009-09-16       Impact factor: 3.452

View more
  20 in total

1.  Predictors of Short-Term Readmission After Pancreaticoduodenectomy.

Authors:  Rajesh Ramanathan; Travis Mason; Luke G Wolfe; Brian J Kaplan
Journal:  J Gastrointest Surg       Date:  2018-02-05       Impact factor: 3.452

Review 2.  General and vascular surgery readmissions: a systematic review.

Authors:  Jason T Wiseman; Amanda M Guzman; Sara Fernandes-Taylor; Travis L Engelbert; R Scott Saunders; K Craig Kent
Journal:  J Am Coll Surg       Date:  2014-05-22       Impact factor: 6.113

3.  Composite Length of Stay, An Outcome Measure of Postoperative and Readmission Length of Stays in Pancreatoduodenectomy.

Authors:  Gregory A Williams; Jingxia Liu; William C Chapman; William G Hawkins; Ryan C Fields; Dominic E Sanford; Majella B Doyle; Chet W Hammill; Adeel S Khan; Steven M Strasberg
Journal:  J Gastrointest Surg       Date:  2019-12-16       Impact factor: 3.452

4.  Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?: a 10-year contemporary experience with 1,173 patients at the Massachusetts General Hospital.

Authors:  Zhi Ven Fong; Cristina R Ferrone; Sarah P Thayer; Jennifer A Wargo; Klaus Sahora; Kimberly J Seefeld; Andrew L Warshaw; Keith D Lillemoe; Mathew M Hutter; Carlos Fernández-Del Castillo
Journal:  J Gastrointest Surg       Date:  2013-09-04       Impact factor: 3.452

5.  Postoperative serum amylase predicts pancreatic fistula formation following pancreaticoduodenectomy.

Authors:  Jordan M Cloyd; Zachary J Kastenberg; Brendan C Visser; George A Poultsides; Jeffrey A Norton
Journal:  J Gastrointest Surg       Date:  2013-08-01       Impact factor: 3.452

6.  Association of discharge home with home health care and 30-day readmission after pancreatectomy.

Authors:  Dominic E Sanford; Margaret A Olsen; Kerry M Bommarito; Manish Shah; Ryan C Fields; William G Hawkins; David P Jaques; David C Linehan
Journal:  J Am Coll Surg       Date:  2014-07-18       Impact factor: 6.113

7.  Specific Medicare Severity-Diagnosis Related Group Codes Increase the Predictability of 30-Day Unplanned Hospital Readmission After Pancreaticoduodenectomy.

Authors:  Dimitrios Xourafas; Katiuscha Merath; Gaya Spolverato; Stanley W Ashley; Jordan M Cloyd; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2018-07-23       Impact factor: 3.452

8.  Early hospital readmission for gastrointestinal-related complications predicts long-term mortality after pancreatectomy.

Authors:  Caitlin W Hicks; Jeffrey J Tosoian; Rebecca Craig-Schapiro; Vicente Valero; John L Cameron; Frederic E Eckhauser; Kenzo Hirose; Martin A Makary; Timothy M Pawlik; Nita Ahuja; Matthew J Weiss; Christopher L Wolfgang
Journal:  Am J Surg       Date:  2015-06-29       Impact factor: 2.565

9.  Investigating Transitional Care to Decrease Post-pancreatectomy 30-Day Hospital Readmissions for Dehydration or Failure to Thrive.

Authors:  Dimitrios Xourafas; Akweley Ablorh; Thomas E Clancy; Richard S Swanson; Stanley W Ashley
Journal:  J Gastrointest Surg       Date:  2016-03-08       Impact factor: 3.452

10.  Tracking early readmission after pancreatectomy to index and nonindex institutions: a more accurate assessment of readmission.

Authors:  Jeffrey J Tosoian; Caitlin W Hicks; John L Cameron; Vicente Valero; Frederic E Eckhauser; Kenzo Hirose; Martin A Makary; Timothy M Pawlik; Nita Ahuja; Matthew J Weiss; Christopher L Wolfgang
Journal:  JAMA Surg       Date:  2015-02       Impact factor: 14.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.